 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 01/21/2021 |
$2.28 |
$2.32 |
$2.04 |
$2.13 |
5.21M | | 01/22/2021 |
$2.10 |
$2.14 |
$2.05 |
$2.10 |
1.39M | | 01/25/2021 |
$2.11 |
$2.22 |
$2.02 |
$2.18 |
3.44M | | 01/26/2021 |
$2.22 |
$2.22 |
$2.11 |
$2.15 |
1.77M | | 01/27/2021 |
$2.10 |
$2.14 |
$2.02 |
$2.03 |
2.01M |
|
|
| AIM ImmunoTech is an immuno-pharma company that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Co.'s primary pharmaceutical product platform consists of Ampligen® and Alferon N Injection®. Ampligen® is approved for sale in Argentina for severe Chronic Fatigue Syndrome (CFS) and is an experimental drug in the U.S. undergoing clinical development for the treatment of certain cancers and myalgic encephalomyelitis/CFS. Alferon® is a natural-source, multi-species alpha interferon for the intralesional treatment of refractory or recurring external genital warts in patients 18 years of age or older. | |
|
AIM ImmunoTech (AIM) has the following price history information. Looking back at AIM historical stock prices for the last five trading days, on January 21, 2021, AIM opened at $2.28, traded as high as $2.32 and as low as $2.04, and closed at $2.13. Trading volume was a total of 5.21M shares. On January 22, 2021, AIM opened at $2.10, traded as high as $2.14 and as low as $2.05, and closed at $2.10. Trading volume was a total of 1.39M shares. On January 25, 2021, AIM opened at $2.11, traded as high as $2.22 and as low as $2.02, and closed at $2.18. Trading volume was a total of 3.44M shares. On January 26, 2021, AIM opened at $2.22, traded as high as $2.22 and as low as $2.11, and closed at $2.15. Trading volume was a total of 1.77M shares. On January 27, 2021, AIM opened at $2.10, traded as high as $2.14 and as low as $2.02, and closed at $2.03. Trading volume was a total of 2.01M shares.
AIM Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AIM ImmunoTech shares, starting with a $10,000 purchase of AIM, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/28/2011 |
|
| End date: |
01/27/2021 |
|
| Start price/share: |
$0.50 |
|
| End price/share: |
$2.03 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
306.00% |
|
| Average Annual Total Return: |
15.03% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$40,592.37 |
|
| Years: |
10.01 |
|
|
|
| Date |
Close |
| 01/21/2021 | $2.13 | | 01/22/2021 | $2.10 | | 01/25/2021 | $2.18 | | 01/26/2021 | $2.15 | | 01/27/2021 | $2.03 |
|
|
